Logo

    6. The White Cataract (Dr. Brian Kim)

    enJune 14, 2023
    What was the main topic of the podcast episode?
    Summarise the key points discussed in the episode?
    Were there any notable quotes or insights from the speakers?
    Which popular books were mentioned in this episode?
    Were there any points particularly controversial or thought-provoking discussed in the episode?
    Were any current events or trending topics addressed in the episode?

    About this Episode

    Even for the more experienced surgeon, a white cataract likely raises their adrenaline level just a tiny bit. Perhaps the biggest concern is – what if I start operating, and I get the dreaded Argentinian flag sign? Or less dramatic, what if the rhexis starts running out and the case becomes more complicated than expected? The reality is, white cataracts can be tough. But are there certain ways to predict when a white cataract might be more complex? What are some effective techniques that can help us maneuver a challenging capsulorhrexis that seems to want to run out to the zonules? Dr. Brian Kim joins the podcast to share pearls on operating on white cataracts.

    Dr. Brian Kim's YouTube Channel
    https://www.youtube.com/channel/UCv0ywA2HPDmfHpEkB_02_Tg

    Recent Episodes from Blind Spot - The Eye Doctor's Podcast

    20. Acute Angle Closure Glaucoma (Dr. Ike Ahmed)

    20. Acute Angle Closure Glaucoma (Dr. Ike Ahmed)
    The traditional paradigm is that when a patient presents with acute angle closure due to pupil block, a peripheral iridotomy (PI) must be performed immediately. But in reality, is this always the best approach? Is it safe to treat medically for a period of time before the PI? In which situations might a PI actually exacerbate the acute angle closure? Dr. Ike Ahmed joins the podcast.

    19. Keratoconus - 'No Rub, No Cone' (Dr. Damien Gatinel)

    19. Keratoconus - 'No Rub, No Cone' (Dr. Damien Gatinel)
    We all know that keratoconus is very highly associated with eye rubbing. But in general, the widely held belief has been that keratoconus is just associated with eye rubbing, one of multiple factors that leads to the condition. But have we gotten it wrong? Is eye rubbing not merely associated with keratoconus, but actually the sole causative factor of keratoconus? Has there been a huge blind spot in our basic understanding of keratoconus development and progression? Dr. Damien Gatinel joins the podcast.

    18. Acetazolamide (Dr. Deborah Friedman)

    18. Acetazolamide (Dr. Deborah Friedman)
    Acetazolamide is a common and important medication used in ophthalmology. It is used as a treatment for both high intraocular pressure and high intracranial pressure. Yet despite its many uses, many ophthalmologists feel nervous when prescribing it due its potential side effects and the concern of sulfa allergy. And while caution is always a good thing, have we perhaps overstated the risks with acetazolamide to such a point that we don’t use it enough? What exactly is sulfa allergy, and does it even apply to acetazolamide? And how dangerous is acetazolamide, and how should we be counseling patients when prescribing it? Dr. Deborah Friedman joins the podcast.

    Learn more about Dr. Friedman at www.neuroeyes.com

    17. Central Retinal Artery Occlusion (Dr. R. Rishi Gupta)

    17. Central Retinal Artery Occlusion (Dr. R. Rishi Gupta)
    A central retinal artery occlusion is arguably one of the worst ocular events that can occur, given its extremely poor visual prognosis. As such, our efforts to find an effective treatment for CRAO have been extensive, but in many regards, inadequate. There are certain treatment options that we all learn in residency to try and halt a CRAO, but for the most part, many of these techniques are fairly unproven and don’t work so well. So what does actually work? And is the evidence for TPA strong enough that we should be routinely recommending it in appropriate cases? Dr. Rishi Gupta joins the podcast.

    Learn more about Dr. Gupta at https://rishiguptamd.com/about/

    Learn more about Dr. Gupta's books at https://rishiguptamd.com/textbooks/

    16. Botox and Fillers (Dr. Harmeet Gill)

    16. Botox and Fillers (Dr. Harmeet Gill)
    Over the past two decades, Botox and Fillers have changed the landscape of cosmetic plastic surgery, including the field of oculoplastics. But how exactly to Botox and Fillers work, and more importantly, how should patients be counseled on these elective treatments? And from a philosophical standpoint, has the world of cosmetic surgery gone too far in 'de-aging' the population and perhaps further stigmatizing the natural process of getting older? Oculoplastics specialist Dr. Harmeet Gill joins the podcast.

    15. Blepharitis (Dr. Ashley Brissette)

    15. Blepharitis (Dr. Ashley Brissette)
    Blepharitis is a common diagnosis, but it’s also an umbrella term that encompasses many different clinical disorders which require varying treatment approaches. Many patients struggle with chronic blepharitis, where it’s tough to find an effective treatment. So what exactly is the best approach to blepharitis? How does one differentiate staph blepharitis from demodex? What are the most effective treatments on the market? And from a preventative standpoint, what exactly is lid hygiene, and is it something we should routinely be recommending to our patients? Dr. Ashley Brissette joins the podcast.

    Check out Dr. Brissette's Eye Care Products
    www.dailypractice.com

    Follow Dr. Brissette on Social Media
    Instagram @abrissettemd
    TikTok @abrissettemd

    14. Flashes and Floaters (Dr. Efrem Mandelcorn)

    14. Flashes and Floaters (Dr. Efrem Mandelcorn)
    Flashes and floaters is one of the most common presenting complaints to eye care professionals. And while most of us understand the general pathophysiology of the vitreous separating from the retina, some of the nuances may not be as clear. Why do flashes and floaters persist so differently in patients? Why do flashes and floaters continue even after a vitrectomy? How common are retinal tears when one experiences new symptoms? And how, ultimately, should this affect our guidelines for monitoring patients who have new flashes and floaters? Dr. Efrem Mandelcorn joins the podcast.

    This episode is sponsored by Canadian Eye Care Today. Access the journal at https://canadianeyecaretoday.com

    13. Viral Conjunctivitis (Dr. Francis Mah)

    13. Viral Conjunctivitis (Dr. Francis Mah)
    Viral conjunctivitis is one of the most common presentations to eye care professionals. It’s typically easy to diagnose, and traditionally, the treatment has simply been cool compresses and observation. But have we been too lax in our treatment of viral conjunctivitis? What, if any, are the roles of steroids, iodine, and antivirals in the treatment of this common condition? Dr. Francis Mah joins the podcast.

    12. How Safe is LASIK (Dr. Guy Kezirian)

    12. How Safe is LASIK (Dr. Guy Kezirian)
    Over the past twenty-five years, LASIK has become one of the most commonly performed ocular procedures. As refractive surgery has become more popular in general, LASIK still remains the mainstay option in younger non-presbyopic populations. Whereas eye care professionals used to be more hesitant about recommending LASIK, the sentiment has largely shifted. But how safe is LASIK and other refractive surgeries? With it becoming so common, have we perhaps overlooked some of the shortcomings of LASIK? Or alternatively, is the boom in refractive surgery justified and actually an important part of the progression of ophthalmology? Dr. Guy Kezirian, Founder of the Refractive Surgery Alliance, joins the podcast.

    11. LipiFlow and IPL (Dr. Ashley Brissette)

    11. LipiFlow and IPL (Dr. Ashley Brissette)
    Lipiflow and IPL have become mainstays in the treatment of meibomian gland disease. But while they might be effective in some cases, they are also quite expensive to patients. Which begs the question – how effective are lipiflow and IPL when compared to more conventional treatments? Is there a way to predict which patients will benefit most from these treatments? Ultimately, how should Lipiflow and IPL factor into the treatment algorithm for meibomian gland disease in a way that is clinically advantageous while also cost-sensitive to the patient? Dr. Ashley Brissette joins the podcast.

    Check out Dr. Brissette's Eye Care Products
    www.dailypractice.com

    Follow Dr. Brissette on Social Media
    Instagram @abrissettemd
    TikTok @abrissettemd
    Logo

    © 2024 Podcastworld. All rights reserved

    Stay up to date

    For any inquiries, please email us at hello@podcastworld.io